Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 279,900 shares at $36.26 ($10.2M) on 2023-03-30, disclosed to the SEC on 2023-03-30.
Open-market sale of $10.2M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.95 | 9,926 | $367K | 3.6% |
| 2 | $36.95 | 9,926 | $367K | 3.6% |
| 3 | $36.26 | 130,024 | $4.7M | 46.4% |
| 4 | $36.26 | 130,024 | $4.7M | 46.4% |
| Total | $36.31 avg | 279,900 | $10.2M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |